CFAP96 and breast carcinoma: In fact, analysis of C4orf47 expression and survival in other carcinomas has shown that the prognosis of lung cancer, breast cancer, and uterine cancer was significantly prolonged in the high C4orf47-expressing group (Supplementary Fig. a).